Pfizer Inc (PFE)
28.44
+0.43
(+1.54%)
USD |
NYSE |
May 13, 16:00
28.46
+0.02
(+0.07%)
Pre-Market: 04:45
Pfizer Gross Profit Margin (Quarterly): 77.29% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 77.29% |
December 31, 2023 | 46.92% |
September 30, 2023 | 29.95% |
June 30, 2023 | 74.58% |
March 31, 2023 | 73.57% |
December 31, 2022 | 60.28% |
September 30, 2022 | 73.22% |
June 30, 2022 | 68.83% |
March 31, 2022 | 61.09% |
December 31, 2021 | 59.16% |
September 30, 2021 | 58.68% |
June 30, 2021 | 62.98% |
March 31, 2021 | 71.36% |
December 31, 2020 | 76.28% |
September 30, 2020 | 80.47% |
June 30, 2020 | 81.49% |
March 31, 2020 | 80.76% |
December 31, 2019 | 75.96% |
September 30, 2019 | 79.48% |
June 30, 2019 | 80.58% |
March 31, 2019 | 81.45% |
December 31, 2018 | 29.52% |
September 30, 2018 | 79.74% |
June 30, 2018 | 78.35% |
March 31, 2018 | 80.14% |
Date | Value |
---|---|
December 31, 2017 | 76.24% |
September 30, 2017 | 78.40% |
June 30, 2017 | 79.37% |
March 31, 2017 | 80.69% |
December 31, 2016 | 76.44% |
September 30, 2016 | 76.35% |
June 30, 2016 | 75.86% |
March 31, 2016 | 78.08% |
December 31, 2015 | 75.72% |
September 30, 2015 | 81.64% |
June 30, 2015 | 81.61% |
March 31, 2015 | 83.08% |
December 31, 2014 | 79.40% |
September 30, 2014 | 80.84% |
June 30, 2014 | 80.72% |
March 31, 2014 | 81.99% |
December 31, 2013 | 79.39% |
September 30, 2013 | 81.91% |
June 30, 2013 | 82.72% |
March 31, 2013 | 81.76% |
December 31, 2012 | 80.18% |
September 30, 2012 | 82.17% |
June 30, 2012 | 82.99% |
March 31, 2012 | 81.56% |
December 31, 2011 | 82.79% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
29.95%
Minimum
Sep 2023
81.49%
Maximum
Jun 2020
68.65%
Average
73.39%
Median
Gross Profit Margin (Quarterly) Benchmarks
Amgen Inc | 57.03% |
Johnson & Johnson | 69.55% |
Eli Lilly and Co | 80.91% |
Viking Therapeutics Inc | -- |
Moderna Inc | 42.52% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -0.32% |
Return on Assets | -0.14% |
Return on Invested Capital | -0.20% |
Profit Margin (Quarterly) | 20.94% |
Operating Margin (Quarterly) | 28.25% |
Return on Net Operating Assets | -0.20% |